Kennedy Krieger Institute

Running trials

• Not yet recruiting

  A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep

  NCT07061470· Phase 1/2· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Not yet recruiting

  Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors

  NCT07558473· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Not yet recruiting

  The Study of Brave-LC LDN Treatment Trial

  NCT07916259· Phase 3· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Recruiting

  Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome

  NCT07778810· Phase 2· Johns Hopkins University· Source

• Recruiting

  Medication Treatment of ADHD in Pediatric Epilepsy

  NCT07594652· Phase 4· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Recruiting

  Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

  NCT07486934· Phase 3· Dyne Therapeutics· Source

• Recruiting

  ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury

  NCT07147296· ONWARD Medical, Inc.· Source

• Recruiting

  Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

  NCT07278388· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Enrolling by invitation

  Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

  NCT07008469· Phase 3· Avidity Biosciences, Inc.· Source

• Recruiting

  Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

  NCT06810180· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Recruiting

  Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)

  NCT06866275· Phase 2· Children's Hospital of Orange County· Source

• Active, not recruiting

  Cognitive Behavioral Therapy for Chronic Pain in Adults With Cerebral Palsy

  NCT06269926· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Recruiting

  A Single-Arm Pilot Trial for Mitigating Relapse of Severe Problem Behavior

  NCT06732219· Auburn University· Source

• Recruiting

  Optimizing Dimensions of Reinforcement

  NCT07137273· Auburn University· Source

• Recruiting

  Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

  NCT04781140· Phase 4· Supernus Pharmaceuticals, Inc.· Source

• Recruiting

  DINO RCT - Treating Anxiety in Children With Autism

  NCT06066983· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Enrolling by invitation

  Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

  NCT06066580· Phase 2· Edgewise Therapeutics, Inc.· Source

• Active, not recruiting

  A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

  NCT06021522· Phase 3· Emalex Biosciences Inc.· Source

• Recruiting

  Imaging the Pathogenesis of Cerebral Small Vessel Disease

  NCT05703386· Johns Hopkins University· Source

• Active, not recruiting

  A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)

  NCT05540860· Phase 2· Edgewise Therapeutics, Inc.· Source

• Enrolling by invitation

  A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

  NCT05398250· University of North Carolina, Chapel Hill· Source

• Recruiting

  Transcutaneous Spinal Cord Stimulation in Children With Incomplete Spinal Cord Injury

  NCT06242873· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Recruiting

  Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

  NCT04421248· Phase 4· Donald Gilbert, MD, MS, FAAN, FAAP· Source

• Enrolling by invitation

  A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

  NCT06606340· Sarepta Therapeutics, Inc.· Source

• Recruiting

  Anatomical and Functional Imaging Correlates of Chronic Pain in Cerebral Palsy

  NCT05197946· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Active, not recruiting

  A Novel Framework for Impaired Imitation in ASD

  NCT03423160· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Recruiting

  The Myelin Disorders Biorepository Project

  NCT03047369· Children's Hospital of Philadelphia· Source

• Active, not recruiting

  Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome

  NCT01425944· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ADHD5 recruiting
• Autism5 recruiting
• Duchenne muscular dystrophy2 recruiting
• Long COVID and ME/CFS2 recruiting
• Myotonic dystrophy2 recruiting
• Spinal cord injury2 recruiting
• Anxiety disorders (generalised anxiety)1 recruiting
• Cerebral palsy1 recruiting
• Charcot-Marie-Tooth disease1 recruiting
• Childhood cancers1 recruiting
• Epilepsy1 recruiting
• High blood pressure1 recruiting
• Restless legs syndrome1 recruiting
• Sjögren's disease1 recruiting
• Stroke1 recruiting
• Vascular dementia1 recruiting

Closed trials

• Terminated

  Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)

  NCT06042257· Phase 2· Rachel G. Greenberg, MD, MB, MHS· Source

• Completed

  Global Study of Del-desiran for the Treatment of DM1

  NCT06411288· Phase 3· Avidity Biosciences, Inc.· Source

• Completed

  A Crisis Prevention Program for Youth With Autism

  NCT05681143· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Completed

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· Phase 2· Edgewise Therapeutics, Inc.· Source

• Completed

  Impact of Iron Supplementation Treatment on Brain Iron Concentrations

  NCT04144790· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Completed

  Defining Endpoints in Becker Muscular Dystrophy

  NCT05257473· Virginia Commonwealth University· Source

• Completed

  Epidiolex® for Anxiety in Pediatric Epilepsy

  NCT05324449· Phase 4· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Completed

  Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

  NCT05059327· Phase 2· Noema Pharma AG· Source

• Completed

  Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

  NCT04997109· Emory University· Source

• Completed

  Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)

  NCT05176808· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

• Completed

  Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome

  NCT04717427· University of Illinois Chicago· Source

• Completed

  Goal Attainment Scaling (GAS) Sub-Study

  NCT06484426· LuMind IDSC Foundation· Source

• Recruiting

  A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

  NCT04777357· Phase 3· AbbVie· Source

• Terminated

  Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD

  NCT04632940· Phase 3· Kyntra Bio· Source

• Completed

  Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy

  NCT03340675· Phase 2· Cumberland Pharmaceuticals· Source

• Completed

  Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)

  NCT03910075· Phase 3· Virginia Polytechnic Institute and State University· Source

• Terminated

  Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

  NCT04149197· LuMind IDSC Foundation· Source

• Completed

  Examining Effects of Holistic School Enrichment Programs

  NCT05118932· Hugo W. Moser Research Institute at Kennedy Krieger, Inc.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Down syndrome8 works · 3 trials
• Tourette syndrome7 works · 1 trial
• Huntington's disease6 works · 0 trials
• Postural tachycardia syndrome (POTS)3 works · 0 trials